{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:24:21Z","timestamp":1790504661536,"version":"4.1.0"},"reference-count":49,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":475,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81171998, 81171999, 81071742, 81272529"],"award-info":[{"award-number":["81171998, 81171999, 81071742, 81272529"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The National Science & Technology Major Project","award":["2009ZX09103-703 and 2009ZX09306-002"],"award-info":[{"award-number":["2009ZX09103-703 and 2009ZX09306-002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2015,1,1]]},"DOI":"10.1002\/ijc.28950","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T08:47:27Z","timestamp":1399279647000},"page":"182-194","source":"Crossref","is-referenced-by-count":46,"title":["Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration"],"prefix":"10.1002","volume":"136","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[{"name":"The National Engineering Laboratory for Anti-Tumor Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Beijing Key Laboratory for Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Cancer Biology Laboratory; School of Life Sciences, Tsinghua University; Beijing 100084 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghua","family":"Liu","sequence":"additional","affiliation":[{"name":"The National Engineering Laboratory for Anti-Tumor Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Beijing Key Laboratory for Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Cancer Biology Laboratory; School of Life Sciences, Tsinghua University; Beijing 100084 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Guo","sequence":"additional","affiliation":[{"name":"The National Engineering Laboratory for Anti-Tumor Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Beijing Key Laboratory for Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Cancer Biology Laboratory; School of Life Sciences, Tsinghua University; Beijing 100084 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"The National Engineering Laboratory for Anti-Tumor Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Beijing Key Laboratory for Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Cancer Biology Laboratory; School of Life Sciences, Tsinghua University; Beijing 100084 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fu","sequence":"additional","affiliation":[{"name":"The National Engineering Laboratory for Anti-Tumor Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Beijing Key Laboratory for Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Cancer Biology Laboratory; School of Life Sciences, Tsinghua University; Beijing 100084 China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhang","family":"Luo","sequence":"additional","affiliation":[{"name":"The National Engineering Laboratory for Anti-Tumor Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Beijing Key Laboratory for Protein Therapeutics; Tsinghua University; Beijing 100084 China"},{"name":"Cancer Biology Laboratory; School of Life Sciences, Tsinghua University; Beijing 100084 China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"issue":"Suppl 4","key":"10.1002\/ijc.28950-BIB0001|ijc28950-cit-0001","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S0959-8049(01)00233-7","article-title":"The EGFR as a target for anticancer therapy-focus on cetuximab","volume":"37","author":"Baselga","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1002\/ijc.28950-BIB0002|ijc28950-cit-0002","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.28950-BIB0003|ijc28950-cit-0003","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2174\/156800909790192365","article-title":"Antibody-drug conjugate targets","volume":"9","author":"Teicher","year":"2009","journal-title":"Current cancer drug targets"},{"key":"10.1002\/ijc.28950-BIB0004|ijc28950-cit-0004","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ijc.22370","article-title":"Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma","volume":"120","author":"Kawaguchi","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28950-BIB0005|ijc28950-cit-0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/ijc.26181","article-title":"Cetuximab +\/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro","volume":"130","author":"Correale","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28950-BIB0006|ijc28950-cit-0006","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1073\/pnas.83.11.3825","article-title":"Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation","volume":"83","author":"Sunada","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/ijc.28950-BIB0007|ijc28950-cit-0007","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1016\/j.yexcr.2006.05.008","article-title":"Effect of the anti-receptor ligand-blocking 225 monoclonal antibody on EGF receptor endocytosis and sorting","volume":"312","author":"Jaramillo","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1002\/ijc.28950-BIB0008|ijc28950-cit-0008","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/jcp.1041420210","article-title":"Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody","volume":"142","author":"Sunada","year":"1990","journal-title":"J Cell Physiol"},{"key":"10.1002\/ijc.28950-BIB0009|ijc28950-cit-0009","first-page":"3154","article-title":"Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells","volume":"63","author":"Mamot","year":"2003","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0010|ijc28950-cit-0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/mp060105u","article-title":"Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells","volume":"4","author":"Yip","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1002\/ijc.28950-BIB0011|ijc28950-cit-0011","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrd1957","article-title":"Antibody targeted drugs as cancer therapeutics","volume":"5","author":"Schrama","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/ijc.28950-BIB0012|ijc28950-cit-0012","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm1571","article-title":"Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling","volume":"6","author":"Roy","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1002\/ijc.28950-BIB0013|ijc28950-cit-0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1002\/ijc.28950-BIB0014|ijc28950-cit-0014","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ymthe.2005.03.038","article-title":"Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes","volume":"12","author":"Rejman","year":"2005","journal-title":"Mol Ther"},{"key":"10.1002\/ijc.28950-BIB0015|ijc28950-cit-0015","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1073\/pnas.0409817102","article-title":"Clathrin-independent endocytosis of ubiquitinated cargos","volume":"102","author":"Sigismund","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/ijc.28950-BIB0016|ijc28950-cit-0016","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1091\/mbc.E04-07-0596","article-title":"Relationships between EGFR Signaling-competent and endocytosis-competent membrane microdomains","volume":"16","author":"Puri","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1002\/ijc.28950-BIB0017|ijc28950-cit-0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbamcr.2005.05.005","article-title":"Growth factor receptors, lipid rafts and caveolae: an evolving story","volume":"1746","author":"Pike","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/ijc.28950-BIB0018|ijc28950-cit-0018","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ncb975","article-title":"Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover (vol 5, pg 410, 2003)","volume":"5","author":"Guglielmo","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1002\/ijc.28950-BIB0019|ijc28950-cit-0019","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrm2799","article-title":"Integrins: masters and slaves of endocytic transport","volume":"10","author":"Caswell","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1002\/ijc.28950-BIB0020|ijc28950-cit-0020","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jnci\/djr070","article-title":"Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations","volume":"103","author":"Lee","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28950-BIB0021|ijc28950-cit-0021","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/jcp.22570","article-title":"Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib","volume":"226","author":"Irwin","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1002\/ijc.28950-BIB0022|ijc28950-cit-0022","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0092-8674(92)90143-Z","article-title":"Caveolin, a protein component of caveolae membrane coats","volume":"68","author":"Rothberg","year":"1992","journal-title":"Cell"},{"key":"10.1002\/ijc.28950-BIB0023|ijc28950-cit-0023","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1182\/blood-2007-01-064428","article-title":"Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin","volume":"110","author":"Shi","year":"2007","journal-title":"Blood"},{"key":"10.1002\/ijc.28950-BIB0024|ijc28950-cit-0024","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2010-12-322867","article-title":"Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1002\/ijc.28950-BIB0025|ijc28950-cit-0025","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1242\/jcs.02627","article-title":"Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis","volume":"118","author":"Taylor","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1002\/ijc.28950-BIB0026|ijc28950-cit-0026","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1158\/0008-5472.CAN-08-4967","article-title":"Harnessing competing endocytic pathways for overcoming the tumor-blood barrier: magnetic resonance imaging and near-infrared imaging of bifunctional contrast media","volume":"69","author":"Migalovich","year":"2009","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0027|ijc28950-cit-0027","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1021\/nn3004845","article-title":"Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines","volume":"6","author":"Tedja","year":"2012","journal-title":"ACS Nano"},{"key":"10.1002\/ijc.28950-BIB0028|ijc28950-cit-0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2012.12.014","article-title":"How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances","volume":"166","author":"Rehman","year":"2013","journal-title":"J Controlled Release"},{"key":"10.1002\/ijc.28950-BIB0029|ijc28950-cit-0029","doi-asserted-by":"crossref","first-page":"14541","DOI":"10.1073\/pnas.1006507107","article-title":"Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis","volume":"107","author":"Bhattacharyya","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/ijc.28950-BIB0030|ijc28950-cit-0030","doi-asserted-by":"crossref","first-page":"24631","DOI":"10.1074\/jbc.M400680200","article-title":"Zinc-stimulated endocytosis controls activity of the mouse ZIP1 and ZIP3 zinc uptake transporters","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.28950-BIB0031|ijc28950-cit-0031","first-page":"6567","article-title":"Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate","volume":"9","author":"Griffiths","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0032|ijc28950-cit-0032","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1158\/1078-0432.CCR-05-0204","article-title":"Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys","volume":"11","author":"Sapra","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0033|ijc28950-cit-0033","first-page":"3751","article-title":"Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor","volume":"46","author":"Deguchi","year":"1986","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0034|ijc28950-cit-0034","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1074\/jbc.M706959200","article-title":"TRPV5 is internalized via clathrin-dependent endocytosis to enter a Ca2+-controlled recycling pathway","volume":"283","author":"Graaf","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1002\/ijc.28950-BIB0035|ijc28950-cit-0035","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/j.1462-5822.2008.01228.x","article-title":"Clathrin-dependent entry of a gingipain adhesin peptide and Porphyromonas gingivalis into host cells","volume":"10","author":"Boisvert","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1002\/ijc.28950-BIB0036|ijc28950-cit-0036","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1158\/0008-5472.CAN-07-0077","article-title":"Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo","volume":"67","author":"Arwert","year":"2007","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0037|ijc28950-cit-0037","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1007\/s10439-010-0093-4","article-title":"A parallel excitation based fluorescence molecular tomography system for whole-body simultaneous imaging of small animals","volume":"38","author":"Liu","year":"2010","journal-title":"Ann Biomed Eng"},{"key":"10.1002\/ijc.28950-BIB0038|ijc28950-cit-0038","first-page":"1002","article-title":"Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies","volume":"44","author":"Masui","year":"1984","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0039|ijc28950-cit-0039","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1078-0432.795.11.2","article-title":"The effects of cetuximab alone and in combination with radiation and\/or chemotherapy in lung cancer","volume":"11","author":"Raben","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0040|ijc28950-cit-0040","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1158\/0008-5472.CAN-07-5659","article-title":"PIK3CA mutation\/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab","volume":"68","author":"Jhawer","year":"2008","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.28950-BIB0041|ijc28950-cit-0041","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1535-7163.MCT-05-0259","article-title":"Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels","volume":"5","author":"Wild","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/ijc.28950-BIB0042|ijc28950-cit-0042","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s002620050475","article-title":"Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck","volume":"46","author":"Bier","year":"1998","journal-title":"Cancer Immunol Immunother"},{"key":"10.1002\/ijc.28950-BIB0043|ijc28950-cit-0043","first-page":"H2205","article-title":"Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis","volume":"277","author":"Russell","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1002\/ijc.28950-BIB0044|ijc28950-cit-0044","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/85.16.1327","article-title":"Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies","volume":"85","author":"Baselga","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28950-BIB0045|ijc28950-cit-0045","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1073\/pnas.96.12.6775","article-title":"Acute cholesterol depletion inhibits clathrin-coated pit budding","volume":"96","author":"Subtil","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/ijc.28950-BIB0046|ijc28950-cit-0046","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1091\/mbc.10.4.961","article-title":"Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles","volume":"10","author":"Rodal","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1002\/ijc.28950-BIB0047|ijc28950-cit-0047","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jcp.20924","article-title":"Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activation","volume":"211","author":"Liu","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1002\/ijc.28950-BIB0048|ijc28950-cit-0048","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-4157(86)90002-X","article-title":"How do the polyene macrolide antibiotics affect the cellular membrane properties?","volume":"864","author":"Bolard","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"10.1002\/ijc.28950-BIB0049|ijc28950-cit-0049","first-page":"67","article-title":"Development of liposomal polyene antibiotics: an historical perspective","volume":"6","author":"Ng","year":"2003","journal-title":"J Pharm Pharm Sci"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.28950","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T14:39:35Z","timestamp":1689172775000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.28950"}},"subtitle":["Enhancement of Uptake and Efficacy of EGFR-Targeted Agents"],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.28950","relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}